J Am Soc Nephrol

• 

  Publication Venue For

  • Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function..  33:1876-1890. 2022
  • Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis..  33:1411-1426. 2022
  • Looking Upstream-The Role of Primary Care in Addressing US Race Inequities in Kidney Health..  33:1249-1251. 2022
  • A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome..  33:718-730. 2022
  • Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study..  33:601-611. 2022
  • Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical Trial..  32:3197-3207. 2021
  • A Rare Autosomal Dominant Variant in Regulator of Calcineurin Type 1 (RCAN1) Gene Confers Enhanced Calcineurin Activity and May Cause FSGS..  32:1682-1695. 2021
  • Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review..  32:1765-1778. 2021
  • SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?.  32:1021-1024. 2021
  • Racial Differences in AKI Incidence Following Percutaneous Coronary Intervention..  32:654-662. 2021
  • Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney..  32:614-627. 2021
  • AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19..  32:161-176. 2021
  • Improving Care for Patients after Hospitalization with AKI..  31:2237-2241. 2020
  • Perspectives on COVID-19 from Singapore: Impact on ESKD Care and Medical Education..  31:2242-2245. 2020
  • Caution in Identifying Coronaviruses by Electron Microscopy..  31:2223-2224. 2020
  • Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function..  31:2083-2096. 2020
  • Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23..  31:2184-2192. 2020
  • Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study..  31:1836-1846. 2020
  • Mortality in US Hemodialysis Patients Following Exposure to Wildfire Smoke..  31:1824-1835. 2020
  • Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients..  31:1661-1664. 2020
  • Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology..  31:1380-1383. 2020
  • At the Crossroads for Intravenous Iron Dosing..  31:1653-1654. 2020
  • Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes..  31:841-854. 2020
  • A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial..  31:161-174. 2020
  • Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients..  30:2399-2411. 2019
  • Tracking HLA Antibody Changes among Kidney Waitlist Candidates: One Protocol May Not Fit All..  30:2042-2044. 2019
  • APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis..  30:2027-2036. 2019
  • Effects of Selonsertib in Patients with Diabetic Kidney Disease..  30:1980-1990. 2019
  • KLF4 in Macrophages Attenuates TNFα-Mediated Kidney Injury and Fibrosis..  30:1925-1938. 2019
  • Twist1 in Infiltrating Macrophages Attenuates Kidney Fibrosis via Matrix Metallopeptidase 13-Mediated Matrix Degradation..  30:1674-1685. 2019
  • A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD..  30:1495-1504. 2019
  • Genetic Identification of Two Novel Loci Associated with Steroid-Sensitive Nephrotic Syndrome..  30:1375-1384. 2019
  • Authors' Reply..  30:1338-1339. 2019
  • Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use..  30:1206-1219. 2019
  • Authors' Reply..  30:1137-1138. 2019
  • Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial..  30:1096-1108. 2019
  • Exome-Based Rare-Variant Analyses in CKD..  30:1109-1122. 2019
  • Outcomes for Hemodialysis Patients Given Cardiopulmonary Resuscitation for Cardiac Arrest at Outpatient Dialysis Clinics..  30:461-470. 2019
  • Survival among Veterans Obtaining Dialysis in VA and Non-VA Settings..  30:159-168. 2019
  • Transcription Factor 21 Is Required for Branching Morphogenesis and Regulates the Gdnf-Axis in Kidney Development..  29:2795-2808. 2018
  • Genetic Variants Associated with Circulating Fibroblast Growth Factor 23..  29:2583-2592. 2018
  • The Human FSGS-Causing ANLN R431C Mutation Induces Dysregulated PI3K/AKT/mTOR/Rac1 Signaling in Podocytes..  29:2110-2122. 2018
  • Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation..  29:919-935. 2018
  • Longitudinal FGF23 Trajectories and Mortality in Patients with CKD..  29:579-590. 2018
  • Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery..  29:260-267. 2018
  • MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration..  29:155-167. 2018
  • Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk..  28:3441-3451. 2017
  • Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function..  28:3034-3043. 2017
  • Global Cardiovascular and Renal Outcomes of Reduced GFR..  28:2167-2179. 2017
  • Humoral Compensation after Bortezomib Treatment of Allosensitized Recipients..  28:1991-1996. 2017
  • Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness..  28:1877-1885. 2017
  • Genetic Variants Associated with Circulating Parathyroid Hormone..  28:1553-1565. 2017
  • Immunologic Effects of the Renin-Angiotensin System..  28:1350-1361. 2017
  • SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function..  28:981-994. 2017
  • BP Control and Long-Term Risk of ESRD and Mortality..  28:671-677. 2017
  • Premature T Cell Senescence in Pediatric CKD..  28:359-367. 2017
  • APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease..  27:3600-3610. 2016
  • Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI..  27:2257-2264. 2016
  • Reduced Racial Disparity in Kidney Transplant Outcomes in the United States from 1990 to 2012..  27:2511-2518. 2016
  • Tubular Secretion in CKD..  27:2148-2155. 2016
  • Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects..  27:814-823. 2016
  • Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling..  27:428-438. 2016
  • Urine Metabolite Profiles Predictive of Human Kidney Allograft Status..  27:626-636. 2016
  • Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion..  26:2953-2962. 2015
  • Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection..  26:2753-2764. 2015
  • Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD..  26:2328-2339. 2015
  • Effect of Genetic African Ancestry on eGFR and Kidney Disease..  26:1682-1692. 2015
  • HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome..  26:1701-1710. 2015
  • A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome..  26:1279-1289. 2015
  • Klotho and phosphate are modulators of pathologic uremic cardiac remodeling..  26:1290-1302. 2015
  • Endothelial cell antibodies associated with novel targets and increased rejection..  26:1161-1171. 2015
  • Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney..  26:1027-1038. 2015
  • A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS..  26:831-843. 2015
  • High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study..  26:946-956. 2015
  • Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1..  26:888-895. 2015
  • Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement..  26:976-985. 2015
  • The biomarker niche for fibroblast growth factor 23 testing in CKD..  26:7-9. 2015
  • Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients..  25:2649-2657. 2014
  • In search of the fountain of youth..  25:2143-2145. 2014
  • Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS..  25:1991-2002. 2014
  • BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial..  25:1554-1562. 2014
  • Patient-reported and actionable safety events in CKD..  25:1564-1573. 2014
  • State medicaid coverage, ESRD incidence, and access to care..  25:1321-1329. 2014
  • Urinary biomarkers of AKI and mortality 3 years after cardiac surgery..  25:1063-1071. 2014
  • Predialysis systolic BP variability and outcomes in hemodialysis patients..  25:799-809. 2014
  • Fibroblast growth factor-23 and cardiovascular events in CKD..  25:349-360. 2014
  • Predialysis health, dialysis timing, and outcomes among older United States adults..  25:370-379. 2014
  • Common variants in Mendelian kidney disease genes and their association with renal function..  24:2105-2117. 2013
  • Plasticity of renal erythropoietin-producing cells governs fibrosis..  24:1599-1616. 2013
  • Adult renal mesenchymal stem cell-like cells contribute to juxtaglomerular cell recruitment..  24:1263-1273. 2013
  • TNXB mutations can cause vesicoureteral reflux..  24:1313-1322. 2013
  • Management of anemia in children receiving chronic peritoneal dialysis..  24:665-676. 2013
  • Mineral metabolites and CKD progression in African Americans..  24:125-135. 2013
  • Partial answers from partial Klotho deficiency..  23:1599-1601. 2012
  • Effects of phosphate binders in moderate CKD..  23:1407-1415. 2012
  • Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function..  23:1389-1397. 2012
  • Biomarkers predict progression of acute kidney injury after cardiac surgery..  23:905-914. 2012
  • The impact of renal function on outcomes of bariatric surgery..  23:885-894. 2012
  • Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis..  23:545-555. 2012
  • AT1 receptors in the collecting duct directly modulate the concentration of urine..  22:2237-2246. 2011
  • Inflammation and the paradox of racial differences in dialysis survival..  22:2279-2286. 2011
  • APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy..  22:1991-1996. 2011
  • Phosphate REINs in the renoprotective benefit of ACE inhibition..  22:1777-1779. 2011
  • Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery..  22:1748-1757. 2011
  • Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality..  22:956-966. 2011
  • Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells..  22:635-648. 2011
  • Use of aspirin associates with longer primary patency of hemodialysis grafts..  22:773-781. 2011
  • CUBN is a gene locus for albuminuria..  22:555-570. 2011
  • TRPC6 enhances angiotensin II-induced albuminuria..  22:526-535. 2011
  • Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells..  22:496-507. 2011
  • The increasing prevalence of atrial fibrillation among hemodialysis patients..  22:349-357. 2011
  • Acute kidney injury in older adults..  22:28-38. 2011
  • Low socioeconomic status associates with higher serum phosphate irrespective of race..  21:1953-1960. 2010
  • Renal actions of RGS2 control blood pressure..  21:1847-1851. 2010
  • The EP4 receptor for prostaglandin E2 in glomerular disease: a good receptor turned bad?.  21:1597-1599. 2010
  • Forging forward with 10 burning questions on FGF23 in kidney disease..  21:1427-1435. 2010
  • A new locus for familial FSGS on chromosome 2p..  21:1390-1397. 2010
  • ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities..  21:1235-1237. 2010
  • Treatment of chronic hyponatremia: now we know how, but do we know when or if?.  21:552-555. 2010
  • Angiotensin II promotes development of the renal microcirculation through AT1 receptors..  21:448-459. 2010
  • Mouse models of diabetic nephropathy..  20:2503-2512. 2009
  • SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation..  20:2546-2555. 2009
  • Reduction of Stat3 activity attenuates HIV-induced kidney injury..  20:2138-2146. 2009
  • Urinary NGAL marks cystic disease in HIV-associated nephropathy..  20:1687-1692. 2009
  • Prediction, progression, and outcomes of chronic kidney disease in older adults..  20:1199-1209. 2009
  • Plasma gelsolin and circulating actin correlate with hemodialysis mortality..  20:1140-1148. 2009
  • Age and comorbidities are effect modifiers of gender disparities in renal transplantation..  20:621-628. 2009
  • Phosphorus binders and survival on hemodialysis..  20:388-396. 2009
  • Gq-dependent signaling upregulates COX2 in glomerular podocytes..  19:2108-2118. 2008
  • Stressed-out podocytes in diabetes?.  19:2035-2037. 2008
  • Active vitamin D and survival..  19:1442-1443. 2008
  • Current views on collapsing glomerulopathy..  19:1276-1281. 2008
  • Impact of activated vitamin D and race on survival among hemodialysis patients..  19:1379-1388. 2008
  • Notch signaling: a common pathway of injury in podocytopathies?.  19:1045-1046. 2008
  • Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones..  19:1197-1203. 2008
  • When is it appropriate to use vasopressin receptor antagonists?.  19:1054-1058. 2008
  • Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation..  19:812-824. 2008
  • CKD increases the risk of age-related macular degeneration..  19:806-811. 2008
  • Medical costs of abnormal serum sodium levels..  19:764-770. 2008
  • Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD..  19:615-623. 2008
  • Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome..  19:365-371. 2008